noscript

News and Announcements

Actinogen Medical Congratulates Professor Colin Masters

  • Published February 06, 2017 2:49PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

During Australia Day celebrations for 2017, Actinogen Medical were congratulating Professor Colin Masters on being appointed an Officer in regards to the General Division of the Order of Australia for:

“Distinguished service to medical research through international and national contributions to understanding Alzheimer’s and other neurogenerative diseases”.

This outstanding achievement, that Professor Masters has attained was announced as “Australia Day Honour”. Currently, Professor Masters is on Actinogen Medical, Xanamem™ Clinical Advisory Board, with also being the Executive Director of the Mental Health Institute, finally taking a position on at the University of Melbourne as a Laureate Professor. Professor Marsters, is also a Senior Deputy Director of the Florey Institute of Neuroscience and Mental Health, and a consultant at the Royal Melbourne Hospital. He has focused much of his career around research for Alzheimer’s disease and other neurodegenerative diseases. With over 35 years’ experience, he is widely acknowledged, globally, for his influence during research on the disease.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now